JP2021519312A5 - - Google Patents
Info
- Publication number
- JP2021519312A5 JP2021519312A5 JP2020551973A JP2020551973A JP2021519312A5 JP 2021519312 A5 JP2021519312 A5 JP 2021519312A5 JP 2020551973 A JP2020551973 A JP 2020551973A JP 2020551973 A JP2020551973 A JP 2020551973A JP 2021519312 A5 JP2021519312 A5 JP 2021519312A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- optionally substituted
- nhc
- group
- membered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862649451P | 2018-03-28 | 2018-03-28 | |
| US62/649,451 | 2018-03-28 | ||
| PCT/US2019/023457 WO2019190885A1 (en) | 2018-03-28 | 2019-03-21 | Calpain modulators and therapeutic uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021519312A JP2021519312A (ja) | 2021-08-10 |
| JP2021519312A5 true JP2021519312A5 (cg-RX-API-DMAC7.html) | 2022-03-03 |
Family
ID=68060735
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020551973A Pending JP2021519312A (ja) | 2018-03-28 | 2019-03-21 | カルパインモジュレーター及びその治療的使用 |
Country Status (20)
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2017292646A1 (en) | 2016-07-05 | 2019-02-07 | Blade Therapeutics, Inc. | Calpain modulators and therapeutic uses thereof |
| US10934261B2 (en) * | 2016-09-28 | 2021-03-02 | Blade Therapeutics, Inc. | Calpain modulators and therapeutic uses thereof |
| CN112166111A (zh) * | 2018-03-28 | 2021-01-01 | 布莱德治疗公司 | 治疗纤维化疾病的方法 |
| EP3820864A4 (en) * | 2018-06-28 | 2022-03-30 | Blade Therapeutics, Inc. | METHOD OF TREATMENT OF HEPATIC FIBROSIS USING CALPAIN INHIBITORS |
| BR112022025037A2 (pt) | 2020-06-10 | 2023-02-14 | Aligos Therapeutics Inc | Compostos antivirais para tratar infecções por coronavírus, picornavírus e norovírus |
| WO2023283256A1 (en) | 2021-07-09 | 2023-01-12 | Aligos Therapeutics, Inc. | Anti-viral compounds |
| US12065428B2 (en) | 2021-09-17 | 2024-08-20 | Aligos Therapeutics, Inc. | Anti-viral compounds |
| AU2023303408A1 (en) | 2022-07-06 | 2024-12-19 | Aligos Therapeutics, Inc. | Anti-viral compounds |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9102462D0 (sv) * | 1991-08-28 | 1991-08-28 | Astra Ab | New isosteric peptides |
| AU4544993A (en) * | 1992-06-24 | 1994-01-24 | Cortex Pharmaceuticals, Inc. | Use of calpain inhibitors in the inhibition and treatment of medical conditions associated with increased calpain activity |
| DE19642591A1 (de) * | 1996-10-15 | 1998-04-16 | Basf Ag | Neue Piperidin-Ketocarbonsäure-Derivate, deren Herstellung und Anwendung |
| US6083944A (en) * | 1997-10-07 | 2000-07-04 | Cephalon, Inc. | Quinoline-containing α-ketoamide cysteine and serine protease inhibitors |
| DE19817459A1 (de) * | 1998-04-20 | 1999-10-21 | Basf Ag | Neue heterozyklische substituierte Amide, Herstellung und Anwendung |
| HK1039110A1 (zh) * | 1999-03-15 | 2002-04-12 | Axys Pharmaceuticals, Inc. | 以新颖的合成物及组分作为蛋白酶抑制剂 |
| WO2005000793A1 (ja) * | 2003-06-26 | 2005-01-06 | Taisho Pharmaceutical Co., Ltd. | 2位置換シクロアルキルカルボン酸誘導体 |
| EP1493739A1 (fr) * | 2003-07-03 | 2005-01-05 | Warner-Lambert Company LLC | Dérivés thiophényliques d'aminoacides, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent |
| AR055395A1 (es) * | 2005-08-26 | 2007-08-22 | Vertex Pharma | Compuestos inhibidores de la actividad de la serina proteasa ns3-ns4a del virus de la hepatitis c |
| US7964624B1 (en) * | 2005-08-26 | 2011-06-21 | Vertex Pharmaceuticals Incorporated | Inhibitors of serine proteases |
| CL2007003879A1 (es) * | 2006-12-29 | 2008-07-04 | Basf Ag | Compuestos derivados de aril-carboxamida; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como alzheimer, epilepsia y parkinson. |
| TWI519530B (zh) * | 2009-02-20 | 2016-02-01 | 艾伯維德國有限及兩合公司 | 羰醯胺化合物及其作為鈣蛋白酶(calpain)抑制劑之用途 |
| US8236798B2 (en) * | 2009-05-07 | 2012-08-07 | Abbott Gmbh & Co. Kg | Carboxamide compounds and their use as calpain inhibitors |
| US9051304B2 (en) * | 2009-12-22 | 2015-06-09 | AbbVie Deutschland GmbH & Co. KG | Carboxamide compounds and their use as calpain inhibitors V |
| MX2013006419A (es) * | 2010-12-09 | 2013-12-16 | Abbvie Inc | Compuestos carboxamida y su uso como inhibidores de calpaina v. |
| EP3107952B1 (en) * | 2014-02-19 | 2018-09-26 | ETH Zurich | Method for the generation of chemical libraries |
| AU2017290705B2 (en) * | 2016-06-29 | 2021-08-26 | Rascal Therapeutics, Inc. | Compounds and compositions for the treatment of cancer |
| US10934261B2 (en) * | 2016-09-28 | 2021-03-02 | Blade Therapeutics, Inc. | Calpain modulators and therapeutic uses thereof |
| CN112166111A (zh) * | 2018-03-28 | 2021-01-01 | 布莱德治疗公司 | 治疗纤维化疾病的方法 |
-
2019
- 2019-03-21 CA CA3095164A patent/CA3095164A1/en active Pending
- 2019-03-21 WO PCT/US2019/023457 patent/WO2019190885A1/en not_active Ceased
- 2019-03-21 PE PE2020001468A patent/PE20212111A1/es unknown
- 2019-03-21 KR KR1020207029538A patent/KR20200139702A/ko not_active Ceased
- 2019-03-21 RU RU2020130022A patent/RU2020130022A/ru unknown
- 2019-03-21 AU AU2019242387A patent/AU2019242387A1/en not_active Abandoned
- 2019-03-21 EP EP19777469.8A patent/EP3774737A4/en not_active Withdrawn
- 2019-03-21 US US17/041,596 patent/US20210009564A1/en not_active Abandoned
- 2019-03-21 BR BR112020019560-0A patent/BR112020019560A2/pt not_active Application Discontinuation
- 2019-03-21 MX MX2020010033A patent/MX2020010033A/es unknown
- 2019-03-21 CN CN201980035887.9A patent/CN112204014A/zh active Pending
- 2019-03-21 SG SG11202008750XA patent/SG11202008750XA/en unknown
- 2019-03-21 JP JP2020551973A patent/JP2021519312A/ja active Pending
- 2019-03-28 TW TW108111017A patent/TW202003472A/zh unknown
- 2019-03-28 AR ARP190100806A patent/AR115303A1/es not_active Application Discontinuation
-
2020
- 2020-09-23 IL IL277548A patent/IL277548A/en unknown
- 2020-09-25 PH PH12020551555A patent/PH12020551555A1/en unknown
- 2020-09-25 CL CL2020002496A patent/CL2020002496A1/es unknown
- 2020-09-30 CO CONC2020/0012359A patent/CO2020012359A2/es unknown
- 2020-10-26 EC ECSENADI202068210A patent/ECSP20068210A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021519764A5 (cg-RX-API-DMAC7.html) | ||
| JP2020500207A5 (cg-RX-API-DMAC7.html) | ||
| JP2023544476A5 (cg-RX-API-DMAC7.html) | ||
| JP2012509891A5 (cg-RX-API-DMAC7.html) | ||
| JP2014531434A5 (cg-RX-API-DMAC7.html) | ||
| JP2024514010A5 (cg-RX-API-DMAC7.html) | ||
| JP2008510691A5 (cg-RX-API-DMAC7.html) | ||
| WO2006098918B1 (en) | Substituted gamma lactams as therapeutic agents | |
| RU2020130012A (ru) | Способ лечения фиброзного заболевания | |
| JP2014502979A5 (cg-RX-API-DMAC7.html) | ||
| JP2002528490A5 (cg-RX-API-DMAC7.html) | ||
| JP2009534405A5 (cg-RX-API-DMAC7.html) | ||
| JP2015164972A5 (cg-RX-API-DMAC7.html) | ||
| TW201010990A (en) | New combination-408 | |
| JP2011527675A5 (cg-RX-API-DMAC7.html) | ||
| RU2014106999A (ru) | Замещенные производные 3-тиазолоаминопропионовой кислоты и их применение в качестве фармацевтических препаратов | |
| RU2468793C2 (ru) | Композиции на основе соединений 2-амино-1,3-пропандиола | |
| JP2024517769A5 (cg-RX-API-DMAC7.html) | ||
| KR20010101922A (ko) | 고혈압 치료를 위한 약제학적 조성물 | |
| RU2006124856A (ru) | Гидронопольные производные в качестве агонистов по отношению к orl1 рецепторам человека | |
| JP2013544786A5 (cg-RX-API-DMAC7.html) | ||
| US20100311756A1 (en) | Methods for delaying the progression of at least one of cardiac hypertrophy, cardiac remodeling or left ventricular function or the onset of heart failure in subjects in need of treatment thereof | |
| JP4011114B2 (ja) | 脳浮腫抑制剤 | |
| RU2005137184A (ru) | Новые производные тропана | |
| WO2012004287A1 (en) | 5-(biphenyl-4-yl)-3-phenyl-1,2,4-oxadiazolyl derivatives as ligands on the sphingosine 1-phosphate (s1p) receptors |